Research at Gaylord
Gaylord Specialty Healthcare offers patients the opportunity to participate in various research projects. Inpatients and outpatients are both eligible to enroll in appropriate studies and will be given all the information necessary to make an informed decision regarding participation. Gaylord staff works with other collaborating facilities to conduct and participate in larger studies, including some at an international level. There are also Gaylord specific studies that are designed and conducted by Gaylord staff.
All research projects conducted at Gaylord are reviewed by our Institutional Review Board, (IRB). This board includes professionals from multiple disciplines throughout Gaylord, as well as two community leaders. Upon IRB approval, the studies are conducted within the guidelines of the submitted protocol. Annual reviews and audits are conducted to ensure projects are compliant. You may rest assured that any research project you are approached to participate in through Gaylord’s staff, has been and maintains IRB approval.
Gaylord’s IRB is compliant with U.S. Federal Government Department of Health and Human Service, Office for Human Research Protections. A Federal Wide Assurance, (FWA00010599) that is valid through Feb. 13, 2022, shows Gaylord’s commitment to comply with the requirements set forth in the regulations for the protection of human subjects. The Federal Wide Assurance defines the responsibilities of the Institution, the IRB, the IRB administrative office and staff, and the investigators to protect human research subjects.
If you have further questions, please contact: GaylordIRB@Gaylord.org
IP & Corporate Partnerships